Daniel Aili

Daniel Aili is a Professor and Head of Unit at Linköping University, affiliated with the Department of Physics, Chemistry and Biology within the Faculty of Science and Engineering. His research focuses on the design and development of functional nanoscale materials for biomedical applications, particularly through molecular self-assembly processes.

• PhD in Molecular Physics, Linköping University (2008)
• MSc in Engineering Biology, Linköping University (2003)
• Postdoctoral training at Nanyang Technological University, Singapore (2010–2011)
• Postdoc in Prof. Molly Stevens' lab, Imperial College London, UK (2009–2010)

His research interests lie at the intersection of soft materials, nanotechnology, and biomedicine. He specializes in creating bioresponsive and biointeractive materials using self-assembly techniques. His work spans biosensors, drug delivery systems, regenerative medicine, and wound healing technologies. A key focus is on hydrogels and bioinks that mimic the extracellular matrix, enabling 3D and 4D bioprinting of tissue-like structures.

Recent publications highlight advancements in nanocellulose-based wound dressings with infection-sensing capabilities, controlled antimicrobial release, and high-density biofabrication for skin regeneration. These studies reflect a strong trend toward translational biomaterials that bridge fundamental science with clinical applications, particularly in diagnostics and regenerative therapies.

Daniel Aili has received numerous scientific honors, including:

• ERC Consolidator Grant
• Wallenberg Academy Fellow (with prolongation)
• Future Research Leader by the Swedish Foundation for Strategic Research
• AkzoNobel Nordic Prize for Surface and Colloid Chemistry (2012)
• Ingvar Carlsson Award (2012)
• Arnbergska Prize from the Royal Swedish Academy of Sciences (2013)

He leads the Laboratory of Molecular Materials and has secured major grants from the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research (SSF), and the European Commission (Horizon 2020). He mentors several PhD students and contributes to large collaborative projects such as the SSF MED-X initiative HEALiX. His lab develops innovative materials that can grow artificial tissues, test cancer drugs, and create smart wound dressings that detect infection—contributing significantly to reducing animal testing and advancing personalized medicine.

Daniel Aili’s research group operates within the interdisciplinary research environment Advanced Functional Materials (AFM) at Linköping University. The team combines expertise in biophysics, bioengineering, polymer chemistry, and materials science to push the boundaries of biomimetic material design. Their work on dynamic hydrogels and modular bioinks enables real-time control over cell behavior and tissue formation, positioning them at the forefront of next-generation regenerative therapies.